Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00586833 · ClinicalTrials.gov registry record
Heart Failure and a Preserved Ejection Fraction
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 51
- Enrollment target
NCT00586833: Completed study, sponsored by Mayo Clinic.
NCT00586833 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00586833 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
This will be a cross sectional study comparing patients with HFpEF and age-matched, non-HF controls recruited from the community. This design will allow for determination of biologically relevant differences in baseline ventricular and vascular function, and importantly, differences in the ability to augment ventricular and vascular function dynamically during exercise stress, when symptoms of HF typically are first noted. The endpoint of exercise-reserve function is novel and has been little examined in the existing HFpEF literature.
Interventions
- PROCEDURE O2 consumption max bike test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-06 |
What the finished NCT00586833 record still lists
NCT00586833 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which O2 consumption max bike test is the first listed.
NCT00586833 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00586833 about?
NCT00586833 is a clinical study titled "Heart Failure and a Preserved Ejection Fraction". This will be a cross sectional study comparing patients with HFpEF and age-matched, non-HF controls recruited from the community. This design will allow for determination of biologically relevant differences in baseline ventricular and vascular function, and importantly, differences in the ability t...
What is the current status of trial NCT00586833?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2007-04. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00586833?
The interventions under investigation include: O2 consumption max bike test (PROCEDURE).
Who is sponsoring clinical trial NCT00586833?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia